Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
1.690
-0.080 (-4.52%)
At close: Jul 24, 2026, 4:00 PM EDT
1.605
-0.085 (-5.01%)
After-hours: Jul 24, 2026, 7:59 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $214.76 million as of July 24, 2026. Its market cap has increased by 129.75% in one year.
Market Cap
214.76M
Enterprise Value
147.77M
1-Year Change
129.75%
Ranking
Category
Stock Price
$1.69
ChartMarket Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $214.76M, an increase of 83.50%. That is a compound annual growth rate of 12.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 214.76M | -12.80% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 228.52M |
| Protara Therapeutics | 225.94M |
| Orchestra BioMed Holdings | 223.95M |
| Anavex Life Sciences | 222.41M |
| AC Immune | 221.22M |
| Coherus Oncology | 217.49M |
| Compugen | 215.65M |
| Cellectis | 214.26M |